{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260505738752/en/NImmune-Biopharma-Announces-Presentations-at-Digestive-Disease-Week-2026-Supporting-a-Differentiated-Profile-and-Superior-Efficacy-of-Oral-Once-Daily-NIM-1324-for-IBD", "message": "News view counter 703103 successfully enlarged"}